|
IL17RA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.97180000000219E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.28489996420456E-09 |
| Normal-vs-Stage2 |
3.249800E-02 |
| Normal-vs-Stage3 |
1.879640E-02 |
| Normal-vs-Stage4 |
5.506400E-02 |
| Stage1-vs-Stage2 |
6.434200E-02 |
| Stage1-vs-Stage3 |
8.817600E-03 |
| Stage1-vs-Stage4 |
9.881500E-03 |
| Stage2-vs-Stage3 |
8.677400E-01 |
| Stage2-vs-Stage4 |
7.387400E-01 |
| Stage3-vs-Stage4 |
8.458200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.45079999972431E-07 |
| Normal-vs-AfricanAmerican |
6.153600E-02 |
| Normal-vs-Asian |
1.428080E-02 |
| Caucasian-vs-AfricanAmerican |
3.747800E-01 |
| Caucasian-vs-Asian |
1.348310E-02 |
| AfricanAmerican-vs-Asian |
1.480490E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.81160000000325E-05 |
| Normal-vs-Female |
2.87410000021637E-07 |
| Male-vs-Female |
1.055650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.066030E-01 |
| Normal-vs-Age(41-60Yrs) |
2.42890000001772E-06 |
| Normal-vs-Age(61-80Yrs) |
1.61716000000034E-05 |
| Normal-vs-Age(81-100Yrs) |
1.757190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.777800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.318800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.576200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.300800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.526400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.058200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.41889999971667E-07 |
| Normal-vs-Grade 2 |
2.26629999988681E-07 |
| Normal-vs-Grade 3 |
2.010800E-04 |
| Normal-vs-Grade 4 |
5.871800E-02 |
| Grade 1-vs-Grade 2 |
6.318100E-02 |
| Grade 1-vs-Grade 3 |
2.432100E-02 |
| Grade 1-vs-Grade 4 |
1.456400E-02 |
| Grade 2-vs-Grade 3 |
1.984360E-01 |
| Grade 2-vs-Grade 4 |
8.101800E-02 |
| Grade 3-vs-Grade 4 |
4.273200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.21390000460553E-08 |
| Normal-vs-ccB subtype |
1.753340E-04 |
| ccA subtype-vs-ccB subtype |
3.231000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.58390000000375E-05 |
| Normal-vs-N1 |
7.239900E-02 |
| N0-vs-N1 |
2.901600E-01 |
|
|
